Phase I study of imatinib mesylate and gemcitabine in patients with refractory solid tumor malignancy
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: E. Poplin, M. Gharibo, L. Rodriquez, Y. Elsayed, M. Wojtowicz, M. Gounder, T. Lagattuta, E. Rubin, M. Egorin
Institutions: UPMC Hillman Cancer Center, Rutgers Cancer Institute
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2248852822